GSK names Emma Walmsley as new chief executive

GSK names Emma Walmsley as new chief executive


Drugmaker GlaxoSmithKline says Emma Walmsley will be the company's new chief executive, replacing Andrew Witty when he retires next March. Walmsley currently runs the company's consumer healthcare division, established as part of a deal in which GSK swapped its cancer-drug unit for Novartis's vaccine business.



from Biotech News